Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cell&Soft is a French deeptech biotech company developing, manufacturing, and marketing soft, mechano-mimetic cell culture substrates for in vitro research and drug discovery. Its products are hydrogel-based culture plates designed to mimic the mechanical properties of human tissues more closely than conventional plastic plates, with the goal of improving the physiological relevance and predictive value of cell-based assays. The company’s product family includes MecaChips, µpattern MecaChips, and MecaTract platforms used in oncology, stem cell research, neurology, cardiology, and respiratory biology. Cell&Soft appears to operate primarily as a commercial research-tools and platform company rather than a therapeutic drug developer, serving academic labs and biopharma customers with standard and custom products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell&Soft.